CT
TMO icon

Columbia Trust’s Thermo Fisher Scientific TMO Stock Holding History

Columbia Trust’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$2.16M Buy
4,072
+701
+21% +$339K 0.98% 28
2023
Q3 		$1.71M Buy
3,371
+5
+0.1% +$2.66K 0.99% 26
2023
Q2 		$1.76M Buy
3,366
+119
+4% +$64.2K 0.99% 26
2023
Q1 		$1.87M Sell
3,247
-610
-16% -$344K 1.08% 20
2022
Q4 		$2.12M Sell
3,857
-192
-5% -$102K 1.18% 16
2022
Q3 		$2.05M Buy
4,049
+88
+2% +$49.2K 1.16% 16
2022
Q2 		$2.15M Buy
3,961
+47
+1% +$25.9K 1.16% 18
2022
Q1 		$2.23M Buy
3,914
+761
+24% +$437K 1.04% 23
2021
Q4 		$1.8M Hold
3,153
– – 0.95% 25
2021
Q3 		$1.8M Buy
3,153
+456
+17% +$250K 0.95% 25
2021
Q2 		$1.36M Buy
2,697
+237
+10% +$112K 0.78% 40
2021
Q1 		$1.12M Buy
2,460
+51
+2% +$24.3K 0.7% 45
2020
Q4 		$1.12M Buy
+2,409
New +$1.13M 0.78% 39
2020
Q2 		$946K Buy
2,613
+163
+7% +$54.6K 0.84% 40
2020
Q1 		$694K Sell
2,450
-134
-5% -$42.3K 0.76% 42
2019
Q4 		$838K Buy
+2,584
New +$784K 0.75% 46

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Columbia Trust's TMO Position: Q4 2023 in Review

Columbia Trust increased its Thermo Fisher Scientific (TMO) stake by 21% in Q4 2023, buying an estimated $339K and bringing the position to 4,072 shares worth $2.16M. The position accounts for 0.98% of the portfolio, ranked #28.

Columbia Trust first reported a position in TMO in Q4 2019 and has held it in 16 quarters since. The position peaked at $2.23M in Q1 2022. 2,487 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

  • Columbia Trust held 4,072 shares of Thermo Fisher Scientific worth $2.16M as of Q4 2023.
  • Columbia Trust bought 701 Thermo Fisher Scientific shares in Q4 2023, an estimated $339K.
  • Thermo Fisher Scientific made up 0.98% of Columbia Trust's portfolio in Q4 2023, its #28 holding.
  • Columbia Trust first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 16 quarters since.
  • Columbia Trust's Thermo Fisher Scientific position peaked at $2.23M in Q1 2022.
  • 2,487 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Columbia Trust's 13F filing for Q4 2023, filed 17 Jan 2024.